Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube
- 8 October 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Archiv für Gynäkologie
- Vol. 289 (2), 241-246
- https://doi.org/10.1007/s00404-013-3041-3
Abstract
Among all gynecological malignancies, ovarian cancer is associated with the highest rate of mortality. Recent findings now propose a pivotal role for the fallopian tube during ovarian cancer pathogenesis. Until recently, ovarian cancer was thought to derive from the ovarian surface epithelium. Nevertheless, attempts to define a precursor lesion from this tissue failed. Instead, prophylactic surgery performed on BRCA mutation carriers and subsequent histological analyses revealed a characteristic pre-neoplastic alteration at the fimbriated end of the fallopian tubes, the so-called serous tubal intraepithelial carcinoma (STIC). By morphology and molecular genetics, STIC was found to resemble serous ovarian cancer. As STIC can also be detected in >60 % of BRCA-unrelated serous ovarian carcinomas, it is now considered to be the precursor of the most common ovarian cancer subtype. Based on this hypothesis, a salpingectomy, i.e., the removal of the post-reproductive fallopian tubes may remove the actual site of tumorigenesis and thereby prevent spreading over the ovarian surface and throughout the peritoneum. Consequently, prophylactic salpingectomy might protect against serous ovarian cancer. Moreover, the procedure interrupts the connection between the uterine cavity and the lesser pelvis. Hence, it prevents the ascension of exfoliated endometrial cells which will likely reduce the incidence of endometrioid and clear cell ovarian cancers. Increasing evidence suggests that serous ovarian cancer originates from the fimbriated distal end of the fallopian tube, whereas the ovary gets only involved at a later stage. Given the lack of suitable screening or early detection strategies for ovarian cancer, post-reproductive salpingectomy deserves serious consideration as a prophylactic intervention that will likely confer significant protection against an often deadly disease.Keywords
This publication has 42 references indexed in Scilit:
- High-Grade Serous Tumor Arising from Fallopian Tube in a BRCA Mutation Carrier after Prophylactic OophorectomyCase Reports in Oncology, 2013
- BRCA, the Oviduct, and the Space and Time Continuum of Pelvic Serous CarcinogenesisInternational Journal of Gynecologic Cancer, 2012
- Ovarian Cancer is an Imported Disease: Fact or Fiction?Current Obstetrics and Gynecology Reports, 2012
- Rethinking ovarian cancer: recommendations for improving outcomesNature Reviews Cancer, 2011
- PIK3CA mutation is an early event in the development of endometriosis‐associated ovarian clear cell adenocarcinomaThe Journal of Pathology, 2011
- Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?American Journal of Obstetrics and Gynecology, 2011
- ARID1AMutations in Endometriosis-Associated Ovarian CarcinomasThe New England Journal of Medicine, 2010
- Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screeningBritish Journal of Cancer, 2010
- Endometrial-Peritoneal Interactions during Endometriotic Lesion EstablishmentThe American Journal of Pathology, 2008
- Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancerThe Journal of Pathology, 2001